LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences
November 14 2024 - 8:00AM
Business Wire
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology
company, today announced Vladimir Makatsaria, Chief Executive
Officer, will present a general business update during fireside
chats at the three following healthcare conferences in New York in
November and December:
- Stifel Healthcare Conference 2024 on Tuesday,
November 19 from 11:30 a.m. - 12:00 p.m. Eastern Time,
- 6th Annual Wolfe Research Healthcare
Conference on Wednesday, November 20 from 1:20 - 1:50 p.m. Eastern
Time, and
- Piper Sandler Healthcare Conference on
Tuesday, December 3 from 10:00 - 10:25 a.m. Eastern Time.
All three fireside chats will stream live with recordings
available afterward. To access event links, visit the LivaNova
website at www.livanova.com/events.
About LivaNova
LivaNova PLC is a global medical technology company built on
nearly five decades of experience and a relentless commitment to
provide hope for patients and their families through medical
technologies, delivering life-changing solutions in select
neurological and cardiac conditions. Headquartered in London,
LivaNova employs approximately 2,900 employees and has a presence
in more than 100 countries for the benefit of patients, healthcare
professionals and healthcare systems worldwide. For more
information, please visit www.livanova.com.
Safe Harbor Statement
This news release contains “forward-looking statements”
concerning the Company’s goals, beliefs, expectations, strategies,
objectives, plans, underlying assumptions, and other statements
that are not necessarily based on historical facts. These
statements include, but are not limited to, statements regarding
participation in upcoming events. Actual events may differ
materially from those indicated in our forward-looking statements
as a result of various factors, including those factors set forth
in Item 1A of the Company’s most recent Annual Report on Form 10-K,
as supplemented by any risk factors contained in Quarterly Reports
on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes
no obligation to update the information contained in this press
release to reflect subsequently occurring events or
circumstances.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241114147994/en/
LivaNova Investor Relations and Media Contacts +1 281-895-2382
Briana Gotlin VP, Investor Relations
InvestorRelations@livanova.com
Deanna Wilke VP, Corporate Communications
Corporate.Communications@livanova.com
LivaNova (NASDAQ:LIVN)
Historical Stock Chart
From Jan 2025 to Feb 2025
LivaNova (NASDAQ:LIVN)
Historical Stock Chart
From Feb 2024 to Feb 2025